/Cap Biotech: Indicative Announcement on Disclosure of 2025 Annual Report and 2026 First Quarter Report

NEWS

Cap Biotech: Indicative Announcement on Disclosure of 2025 Annual Report and 2026 First Quarter Report

Shenzhen Stock Exchange

2026/04/29

Securities code: 300639 Securities abbreviation: Kaipu Biotechnology Announcement number: 2026-022

Guangdong Kaipu Biotechnology Co., Ltd.

Disclosure Notice for the 2025 Annual Report and the 2026 First Quarter Report

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.

The "2025 Annual Report", "2025 Annual Report Summary" and "2026 First Quarter Report" of Guangdong Kaipu Biotechnology Co., Ltd. have been disclosed on April 29, 2026 on the GEM Information Disclosure Website designated by the China Securities Regulatory Commission (http://www.cninfo.com.cn/). Investors are advised to check.

Announcement is hereby made.

Board of Directors of Guangdong Kaipu Biotechnology Co., Ltd.

April 29, 2026